Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hyperprogression of cutaneous T cell lymphoma after anti-PD-1 treatment. | JCI Insight | 2023 | 36649072 | PubTator, text mining | PubMed |
| Unique Habitat of Karst Tiankengs Changes the Taxonomy and Potential Metabolism of Soil Microbial Communities. | Microbiol Spectr | 2023 | 36648219 | PubTator, text mining | PubMed |
| Role of myeloid-derived suppressor cells in tumor recurrence. | Cancer Metastasis Rev | 2023 | 36640224 | PubTator, text mining | PubMed |
| Peripheral B cells from patients with hepatitis C virus-associated lymphoma exhibit clonal expansion and an anergic-like transcriptional profile. | iScience | 2023 | 36619973 | PubTator, text mining | PubMed |
| TWN-RENCOD: A novel method for protein binding site comparison. | Comput Struct Biotechnol J | 2023 | 36618985 | PubTator, text mining | PubMed |
| Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer. | Clin Epigenetics | 2023 | 36611170 | PubTator, text mining | PubMed |
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study. | J Clin Oncol | 2023 | 36608310 | PubTator, text mining | PubMed |
| Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management. | Am J Hematol | 2023 | 36588395 | PubTator, text mining | PubMed |
| Pharmacological strategies for mitigating anti-TNF biologic immunogenicity in rheumatoid arthritis patients. | Curr Opin Pharmacol | 2023 | 36580770 | PubTator, text mining | PubMed |
| A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease. | Transplant Cell Ther | 2023 | 36577483 | PubTator, text mining | PubMed |
| The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer. | Immunity | 2023 | 36574773 | PubTator, text mining | PubMed |
| The role of Th17 cells in chronic lymphocytic leukemia: friend or foe? | Blood Adv | 2023 | 36574293 | PubTator, text mining | PubMed |
| Moving towards biologically informed treatment strategies for T-cell lymphomas. | Int J Hematol | 2023 | 36574170 | PubTator, text mining | PubMed |
| Can Molecular Classifications Help Tailor First-line Treatment of Metastatic Renal Cell Carcinoma? A Systematic Review of Available Models. | Eur Urol Open Sci | 2023 | 36573246 | PubTator, text mining | PubMed |
| Alopecia Areata in Latin America: Where are We and Where are We Going? | Dermatol Ther (Heidelb) | 2023 | 36527577 | PubTator, text mining | PubMed |
| Integrated analysis of racial disparities in genomic architecture identifies a trans-ancestry prognostic subtype in bladder cancer. | Mol Oncol | 2023 | 36495164 | PubTator, text mining | PubMed |
| Managing Waldenström's macroglobulinemia with BTK inhibitors. | Leukemia | 2023 | 36402930 | PubTator, text mining | PubMed |
| Targeting Ibrutinib to Tumor-Infiltrating T Cells with a Sialic Acid Conjugate-Modified Phospholipid Complex for Improved Tumor Immunotherapy. | Mol Pharm | 2023 | 36382950 | PubTator, text mining | PubMed |
| Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis. | J Exp Med | 2023 | 36326697 | PubTator, text mining | PubMed |
| Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD. | Blood Adv | 2023 | 36322878 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=22